Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 2

2(50.0%)

N/A

1(25.0%)

Phase 1

1(25.0%)

4Total

Phase 2(2)

N/A(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT06265051Phase 2Completed

Tirofiban After Successful MT Recanalization in AIS

Role: collaborator

NCT07318948Not ApplicableNot Yet Recruiting

BALANCE Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

Role: collaborator

NCT05715710Recruiting

Correlation Between Deep Medullary Veins and Cognitive Dysfunction in Cerebral Small Vessel Disease

Role: lead

NCT05794425Phase 1Recruiting

Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders

Role: collaborator

NCT03341377Completed

Perioperative Symptom Study of Lung Cancer (CN-PRO-Lung 1)

Role: collaborator

NCT03411967Phase 2Unknown

Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC

Role: lead

All 8 trials loaded